Evaluation of eye safety of test product
- Registration Number
- CTRI/2022/07/043782
- Lead Sponsor
- ONESTO LABS PVT LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Indian Female subjects
2.Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
3.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarâ?¦.)
4.Having normal eye conditions
5.Having habit of using under eye cream
6.Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
7.Having refused to give his/her assent by not signing the consent form
8.Taking part in another study liable to interfere with this study
9.Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months)
10.Having a progressive asthma (either under treatment or last fit in the last 2 years)
11.Being epileptic.
12.Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
13.Having cutaneous hypersensitivity
14.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
15.Following a chronic medicinal treatment comprising any of the following products: aspirin based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)
16.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
17.Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit
18.Having applied a cosmetic product (included make-up) or skin care product on the studied areas the first day of the study (only face cleaned with water is accepted)
19.Refusing to follow the restrictions below during the study: Do not take part in any family planning activities leading to pregnancy and breastfeeding Do not take part in another study liable to interfere with this study Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). Mascot Spincontrol 10 / 21 Product A XXX-6Y01-DD-JE22-XXX-PR (V01) Reference of the specification SPE-CNL-PM02-Main Part of Protocol-02-I This document is the property of Mascot Spincontrol. D:QASTUDY DOCUMENTSXXX-6Y01-DD-JE22XXX-6Y01-DD-JE22-XXX- PR (V01) 2022 06 18.docx Do not change cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit. During the study: Do not use other eye related and/ or eye make up than the tested products to the studied areas. The day of the measurements: No test product or any other eye make up must be used
20.Having applied make-up products on eyes in the 48 hours preceding the start of the study.
21.Having permanent make-up on the studied area.
22.Having ocular problems (stye, chalazion, conjunctivitis).
23.Having applied an eye product and/or make up for eye, to the studied area the day of the measurements.
24.Do not itch the eyes
25.Do not use any eye drops or any eye treatment/ surgery during the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Opthalmological SafetyTimepoint: T0, 30 minutes, day 1, Day 3
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil